LAWRENCE H FONGSummaryAffiliation: University of California Country: USA Publications
Research Grants
| Collaborators |
Detail Information
Publications
Immunotherapy for prostate cancerLawrence Fong
University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA
Curr Urol Rep 7:239-46. 2006..Emerging trials have demonstrated that immunotherapy may not only generate immune responses in patients, but also clinical responses. Future studies will be directed at capitalizing on these findings...
Immunotherapy for prostate cancerLawrence Fong
University of California, San Francisco, San Francisco, CA 94143 0511, USA
Curr Oncol Rep 9:226-33. 2007..Emerging trials have demonstrated that immunotherapy may generate not only immune responses in patients but also clinical responses. Future studies will be directed at capitalizing on these findings...
Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSFLawrence Fong
Division of Hematology Oncology, University of California, San Francisco, San Francisco, California 94143, USA
Cancer Res 69:609-15. 2009....
Immunotherapy for prostate cancer: biology and therapeutic approachesEdward Cha
University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA
J Clin Oncol 29:3677-85. 2011....
Research Grants
- DENDRITIC CELL IMMUNOTHERAPY FOR LUNG AND COLON CANCERLawrence Fong; Fiscal Year: 2003..The proposed studies will provide the foundation for simplified yet more potent DC targeted cancer immunotherapy for the future. ..
